NASDAQ · ADUS

Addus HomeCare Corp.

$114.55 +$2.63 (+2.35%) 1D After hours
Charting by TradingView

Key Metrics

$2.09B
Market cap
543.86×
P/E · TTM
$25.90M
Revenue · TTM
$3.84M
Net income
EPS · TTM $0.21
Dividend yield —
Free cash flow —
Beta · 1Y 0.36
EBITDA · TTM —
Gross margin 31.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 24
    The stock moved -10.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.09B
Enterprise value—
Shares outstanding18.7M
52-wk range$87.95 – $124.44
Avg volume · 20D133.9K
Net cash —
Book value / share$60.96
IndustryServices-Home Health Care Services
ExchangeNASDAQ
About Addus HomeCare Corp.
IPO dateOct 27, 2009
Employees50659

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E543.86
P/S80.65
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №$16.96

Profitability

Gross 31.6%
Operating 13.7%
Net 14.8%
FCF —
ROE / ROIC 0.4% · —

Financial Health

Current ratio1.83
Quick ratio—
Debt / equity0.08
Debt / EBITDA —
Net cash —
Working capital$123.40M

Cash Flow · TTM

Operating CF —
Capex —
Free cash flow —
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

4.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$16.96 vs $114.55
Trades 6.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings